Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors.

The Journal of clinical endocrinology and metabolism - 1 Jun 2020

Marques Pedro, Caimari Francisca, Hernández-Ramírez Laura C, Collier David, Iacovazzo Donato, Ronaldson Amy, Magid Kesson, Lim Chung Thong, Stals Karen, Ellard Sian, Grossman Ashley B, Korbonits Márta

Abstract excerpt

CONTEXT: Germline mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene are responsible for a subset of familial isolated pituitary adenoma (FIPA) cases and sporadic pituitary neuroendocrine tumors (PitNETs). OBJECTIVE: To compare prospectively diagnosed AIP mutation-positive (AIPmut) PitNET patients with clinically presenting patients and to compare the clinical characteristics of AIPmut and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Genetic Testing

Share to Intracellular Signaling Peptides and Proteins

Share to Mass Screening

Share to Pituitary Neoplasms

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 31996917
DOI: 10.1210/clinem/dgaa040
PMCID: PMC7137887

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors.PMID 31996917Read ↗

Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.Semantic proximity Read ↗

Familial pituitary adenomas – who should be tested for AIP mutations?Semantic proximity Read ↗

Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.Semantic proximity Read ↗

Genetic, Molecular and Clinical Features of Familial Isolated Pituitary AdenomasSemantic proximity Read ↗

Familial isolated pituitary adenomas: an emerging clinical entity.Semantic proximity Read ↗

Familial isolated pituitary adenoma: evidence for genetic heterogeneity.Semantic proximity Read ↗

Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.Semantic proximity Read ↗

Aryl hydrocarbon receptor interacting protein and syndromic gene variants detected in Turkish isolated pituitary adenoma families by whole exome sequencingSemantic proximity Read ↗

Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein geneSemantic proximity Read ↗

Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma.Semantic proximity Read ↗

The clinical, pathological, and genetic features of familial isolated pituitary adenomasSemantic proximity Read ↗

Molecular genetics of the aip gene in familial pituitary tumorigenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.